Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global treatment devices for hemorrhoid market was valued at USD 721.5 million in 2024. The market is projected to grow from USD 753.4 million in 2025 to USD 1,043.2 million by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period.
Treatment devices for hemorrhoids are specialized medical instruments designed for the diagnosis and management of hemorrhoidal disease, a prevalent condition affecting a significant portion of the adult population. These devices facilitate minimally invasive procedures, aiming to reduce pain, bleeding, and prolapse associated with internal and external hemorrhoids. The primary product categories include band ligators, which mechanically strangulate hemorrhoidal tissue; infrared coagulators that use thermal energy to sclerose vessels; proctoscopes and anoscopes for visualization; as well as bipolar systems and doppler-guided hemorrhoidal artery ligation probes.
The market growth is primarily driven by the high and rising global prevalence of hemorrhoidal disease, which is estimated to affect over one billion people worldwide. Furthermore, the increasing adoption of minimally invasive surgical techniques over traditional hemorrhoidectomy, due to benefits like reduced postoperative pain and shorter recovery times, is a significant contributor. The aging global population, which is more susceptible to the condition, and rising healthcare expenditure in emerging economies further support market expansion. Key players such as Medtronic, Boston Scientific, and Johnson & Johnson (Ethicon) are continuously innovating, with recent developments focusing on enhancing the efficacy and patient comfort of these devices.
Rising Prevalence and Increasing Awareness
The global market for hemorrhoid treatment devices is primarily driven by the increasing prevalence of hemorrhoidal disease, largely attributed to modern sedentary lifestyles, diets low in fiber, and rising obesity rates. Public awareness about the availability of effective, minimally invasive treatment options is growing, prompting more individuals to seek medical care rather than endure discomfort. This shift is crucial for market expansion.
Technological Advancements in Minimally Invasive Procedures
Significant advancements in medical technology have led to the development of highly effective and less painful treatment devices. Procedures such as rubber band ligation, infrared coagulation, and sclerotherapy are increasingly preferred over traditional surgical hemorrhoidectomy due to their benefits, including reduced recovery times, lower risk of complications, and the ability to be performed in outpatient settings.
The global market is projected to grow at a compound annual growth rate of approximately 5.5%, reflecting strong underlying demand drivers.
Furthermore, the growing geriatric population, which is more susceptible to hemorrhoids, and the expansion of healthcare infrastructure in emerging economies are providing a sustained boost to the adoption of these medical devices.
MARKET CHALLENGES
High Cost of Advanced Treatment Devices
The significant cost associated with advanced hemorrhoid treatment devices, such as staplers for procedure for prolapse and hemorrhoids (PPH) and laser systems, poses a major challenge. This can limit their adoption, particularly in cost-sensitive markets and public healthcare systems with constrained budgets, potentially slowing market penetration.
Other Challenges
Patient Hesitancy and Preference for Conservative Management
A substantial number of patients initially opt for conservative management using over-the-counter creams and lifestyle changes, often delaying definitive treatment with medical devices. This hesitancy, often due to embarrassment or fear of procedures, can restrict the immediate addressable market for device-based therapies.
Stringent Regulatory Hurdles
Obtaining regulatory approvals (such as from the FDA or CE marking) for new and innovative devices is a lengthy and expensive process. These regulatory barriers can delay product launches and increase the overall cost of development for manufacturers.
Availability of Alternative Treatment Modalities
The market growth for hemorrhoid treatment devices is restrained by the presence and effectiveness of alternative treatments. Pharmaceutical options, including topical analgesics and anti-inflammatory drugs, remain a first-line treatment for many, while traditional surgery, though more invasive, is still a standard for severe cases. This competition limits the market share for device-based interventions.
Lack of Skilled Professionals
The effective and safe use of many advanced hemorrhoid treatment devices requires specialized training and expertise. A shortage of healthcare professionals proficient in techniques like Doppler-guided hemorrhoidal artery ligation (DG-HAL) or laser procedures in certain regions can act as a significant barrier to the widespread adoption of these technologies.
Expansion in Emerging Economies
Emerging economies in Asia-Pacific, Latin America, and the Middle East present significant growth opportunities. Rising disposable incomes, improving healthcare access, and growing medical tourism for affordable treatments are key factors driving demand. Companies can capitalize on this by expanding their distribution networks and offering cost-effective solutions.
Development of Innovative and User-Friendly Devices
There is a substantial opportunity for companies that invest in R&D to create next-generation devices that are more efficient, less painful, and easier for physicians to use. Innovations focusing on reduced procedure times, enhanced patient comfort, and disposable, single-use devices to prevent cross-contamination are expected to gain significant market traction.
Strategic Collaborations and Acquisitions
Strategic partnerships between device manufacturers and healthcare providers or academic institutions can accelerate product development and market penetration. Furthermore, mergers and acquisitions allow larger players to consolidate the market and integrate innovative technologies into their portfolios, creating stronger competitive advantages.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Band Ligators are recognized as a leading choice among treatment devices due to their established efficacy for internal hemorrhoids and associated high patient satisfaction rates; this minimally invasive technique is favored for its procedural simplicity and strong clinical outcomes. The Infrared Coagulators segment is also a significant contender, valued for delivering precise thermal coagulation with minimal patient discomfort. Continuous technological advancements across all device types are enhancing procedural safety and effectiveness, thereby fostering sustained market growth as providers seek reliable, office-based treatment solutions. |
| By Application |
|
Hospitals and Clinics constitute the dominant application segment for hemorrhoid treatment devices, leveraging their comprehensive infrastructure and capacity to manage a high volume of diverse procedures, including complex cases. The growing preference for minimally invasive treatments has significantly increased the adoption of these devices in clinical settings. Concurrently, Ambulatory Surgery Centers are experiencing rapid growth, driven by their cost-efficiency and focus on providing convenient, same-day surgical procedures, which aligns perfectly with the nature of most hemorrhoid treatments and evolving patient preferences for outpatient care. |
| By End User |
|
Colorectal Surgeons are the primary end users and major influencers in this market, given their specialized training and focus on anorectal disorders, which positions them at the forefront of adopting advanced treatment technologies. Gastroenterologists also represent a substantial user base, frequently performing diagnostic and therapeutic procedures for hemorrhoids during endoscopic evaluations. The expanding pool of trained specialists globally, coupled with heightened awareness of minimally invasive treatment options, is a key factor driving consistent demand for advanced hemorrhoid treatment devices across these professional segments. |
| By Technology |
|
Minimally Invasive technology represents the most dynamic and preferred segment, characterized by devices like band ligators and infrared coagulators that offer significant advantages such as reduced patient recovery time, lower complication rates, and the ability to be performed in outpatient settings. This trend is strongly supported by both patient demand for less painful treatments and clinical evidence demonstrating favorable outcomes. While conventional surgical methods remain necessary for severe cases, the ongoing innovation and physician training are progressively shifting the standard of care towards these advanced, minimally invasive technological solutions. |
| By Procedure Setting |
|
Out-patient/Office-based procedure settings are increasingly becoming the norm for hemorrhoid treatment, driven by the widespread availability and suitability of minimally invasive devices that do not require general anesthesia or extensive hospital resources. This shift is strongly influenced by healthcare cost-containment pressures and the demonstrated clinical success of office-based procedures, which offer greater convenience and accessibility for patients. The design of modern treatment devices increasingly prioritizes portability and ease of use specifically for these ambulatory environments, cementing this segment's leadership role in the market's evolution. |
A Market Dominated by Established MedTech Leaders and Specialized Innovators
The global treatment devices for hemorrhoid market is characterized by the presence of a few dominant multinational medical technology corporations that hold significant market share, alongside several specialized companies focusing on niche product segments. Market leaders Medtronic and Ethicon (a part of Johnson & Johnson) leverage their extensive global distribution networks, broad product portfolios spanning various surgical disciplines, and strong brand recognition to maintain a leading position. Their offerings often include advanced energy-based devices like electrotherapy systems and staplers used in hemorrhoidectomy procedures. Boston Scientific is another key player, contributing with its expertise in minimally invasive technologies. The competitive dynamics are influenced by continuous technological advancements aimed at improving patient outcomes through less painful, minimally invasive procedures with shorter recovery times.
Beyond the major players, the market includes several important companies that have carved out significant niches. Companies like Cook Medical and ConMed are well-established providers of medical devices, including band ligators and anoscopes essential for office-based hemorrhoid treatments. Specialized firms have gained prominence by focusing specifically on proctology. THD SpA is a notable example, known for its Doppler-guided hemorrhoidal artery ligation (DG-HAL) system, which represents a targeted, minimally invasive approach. Similarly, Micro-Tech Endoscopy and Rocket Medical offer a range of disposable and reusable devices catering to the growing demand for outpatient treatments. Integra LifeSciences provides solutions for wound management and surgical care that are relevant in post-procedure care. This landscape is completed by other manufacturers supplying essential equipment like infrared coagulators and bipolar systems, contributing to a diverse and competitive environment focused on improving standard of care.
List of Key Treatment Devices for Hemorrhoid Companies ProfiledMedtronic
Boston Scientific
ConMed
Rocket Medical
Integra LifeSciences Corporation
Sklar Surgical Instruments
MedGyn Products, Inc.
Advin Health Care
Steris
CooperSurgical, Inc.
The global Treatment Devices for Hemorrhoid market is experiencing significant growth, propelled by an increasing global demand for advanced, minimally invasive healthcare services. The market, valued at millions in 2024, is projected to reach a multi-million dollar valuation by 2032, reflecting a notable Compound Annual Growth Rate. This expansion occurs within the broader medical devices market, estimated at $603 billion in 2023 and growing at 5% annually, underscoring the significant role of medical technology in a healthcare sector that constitutes 10% of global GDP. Key drivers include the growing geriatric population, rising healthcare expenditure, and heightened awareness of early diagnosis and treatment options for common ailments like hemorrhoids.
Other TrendsPreference for Minimally Invasive Procedures
A dominant trend is the marked shift towards minimally invasive surgical (MIS) devices, which offer benefits such as reduced pain, shorter hospital stays, and faster recovery times compared to traditional surgery. Device segments like Band Ligators and Infrared Coagulators are at the forefront of this trend, gaining popularity in both hospitals and ambulatory surgery centers. This preference is shaping product development and competitive strategies among leading manufacturers.
Market Segmentation and Regional Dynamics
The market is segmented by device type, including Band Ligators, Infrared Coagulators, Proctoscopes & Anoscopes, Bipolar Systems, and Doppler Probes. Hospitals and Clinics represent the largest application segment, driven by high patient volume and procedural complexity. Geographically, North America holds a significant market share due to advanced healthcare infrastructure and high adoption rates of new technologies. However, the Asia-Pacific region is anticipated to exhibit the fastest growth, fueled by expanding healthcare access, rising medical tourism, and increasing healthcare spending in emerging economies.
Consolidation and Strategic Moves by Key PlayersThe competitive landscape features established medical technology companies like Medtronic, Ethicon (Johnson & Johnson), and Boston Scientific. These players are focusing on strategic initiatives such as mergers, acquisitions, and new product developments to strengthen their market positions. The focus remains on innovation to enhance device efficacy, safety, and user-friendliness, addressing both physician needs and patient outcomes in the treatment of hemorrhoidal disease.
Regional Analysis: Treatment Devices for Hemorrhoid MarketEurope
Europe represents a mature and significant market for hemorrhoid treatment devices, characterized by high standards of healthcare and strong regulatory oversight. The region benefits from universal healthcare systems in many countries, which facilitate patient access to treatment. There is a notable preference for minimally invasive procedures, driving demand for devices like staplers for hemorrhoidopexy and advanced ligation systems. Stringent CE marking requirements ensure that devices meet high safety and performance standards, influencing market entry. Variations in reimbursement policies and healthcare spending across different European nations create a diverse market landscape, with Western Europe showing higher adoption rates of new technologies compared to some Eastern European countries. The aging population is also a contributing factor to steady market demand.
Asia-Pacific
The Asia-Pacific region is experiencing the fastest growth in the hemorrhoid treatment devices market, driven by improving healthcare infrastructure, rising medical tourism, and increasing awareness of treatable conditions. Countries like Japan, China, and India are key contributors, with growing investments in healthcare and a large patient base. The market is transitioning from traditional surgical methods to a greater adoption of minimally invasive devices, though cost sensitivity remains a factor in many areas. Local manufacturing is also increasing, which may influence pricing and availability. The diversity in economic development across the region leads to varying levels of technology adoption, with metropolitan areas leading the way in using advanced treatment options.
South America
The South American market for hemorrhoid treatment devices is developing, with growth potential linked to economic stability and healthcare modernization. Brazil and Argentina are the most prominent markets, where urban healthcare centers are increasingly equipped with modern medical devices. The adoption of new technologies is gradual, often influenced by cost considerations and the availability of trained specialists. Economic fluctuations can impact public healthcare funding and, consequently, the procurement of advanced medical equipment. Private healthcare sectors in major cities are the primary drivers for the adoption of sophisticated treatment devices, catering to a more affluent patient population.
Middle East & Africa
The Middle East and Africa region presents a mixed scenario for the hemorrhoid treatment devices market. The Gulf Cooperation Council (GCC) countries, with their high per capita income and advanced medical facilities, represent a sophisticated market with demand for high-end devices. In contrast, many parts of Africa face challenges related to healthcare access and infrastructure, limiting the widespread use of advanced treatment options. The market growth is largely concentrated in urban centers and private hospitals that serve expatriate and affluent local populations. Medical tourism in certain countries, such as the UAE, also contributes to demand for advanced procedural devices.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Autom, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global treatment devices for hemorrhoid market was valued at USD 721.5 million in 2024 and is expected to reach USD 1,043.2 million by 2032.
Which key companies operate in Global Treatment Devices for Hemorrhoid Market?
-> Key players include Medtronic, Ethicon(Johnson&Johnson), Boston Scientific, Micro-Tech Endoscopy, ConMed, Cook Medical, Rocket Medical, THD SpA, and Integra LifeSciences Corporation, among others.
-> Key growth drivers include high global prevalence of hemorrhoidal disease, aging population, and adoption of minimally invasive procedures.
-> North America holds the largest market share, while Asia-Pacific exhibits the fastest growth rate.
-> Emerging trends include advanced minimally invasive technologies, product innovations, and increasing healthcare expenditure in emerging markets.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates